Search

Your search keyword '"Ghilardi, R"' showing total 2 results
Start Over Author "Ghilardi, R" Topic bone marrow transplantation
2 results on '"Ghilardi, R"'

1. Congenital and acquired neutropenias consensus guidelines on therapy and follow-up in childhood from the Neutropenia Committee of the Marrow Failure Syndrome Group of the AIEOP (Associazione Italiana Emato-Oncologia Pediatrica).

Author

Fioredda F, Calvillo M, Bonanomi S, Coliva T, Tucci F, Farruggia P, Pillon M, Martire B, Ghilardi R, Ramenghi U, Renga D, Menna G, Pusiol A, Barone A, Gambineri E, Palazzi G, Casazza G, Lanciotti M, and Dufour C

Subjects
Antineoplastic Combined Chemotherapy Protocols pharmacology, Bone Marrow drug effects, Bone Marrow pathology, Child, Consensus, Disease Management, Drug Administration Schedule, Granulocyte Colony-Stimulating Factor pharmacology, Humans, Neutropenia classification, Neutropenia pathology, Transplantation, Autologous, Transplantation, Homologous, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Bone Marrow Transplantation, Granulocyte Colony-Stimulating Factor therapeutic use, Neutropenia therapy
Abstract

The management of congenital and acquired neutropenias presents some differences according to the type of the disease. Treatment with recombinant human granulocyte-colony stimulating factor (G-CSF) is not standardized and scanty data are available on the best schedule to apply. The frequency and the type of longitudinal controls in patients affected with neutropenias are not usually discussed in the literature. The Neutropenia Committee of the Marrow Failure Syndrome Group (MFSG) of the Associazione Italiana di Emato-Oncologia Pediatrica (AIEOP) elaborated this document following design and methodology formerly approved by the AIEOP board. The panel of experts reviewed the literature on the topic and participated in a conference producing a document that includes recommendations on neutropenia treatment and timing of follow-up.

Published
2012
Full Text
View/download PDF

2. Congenital and acquired neutropenias consensus guidelines on therapy and follow-up in childhood from the Neutropenia Committee of the Marrow Failure Syndrome Group of the AIEOP (Associazione Italiana Emato-Oncologia Pediatrica)

Author

Roberta Ghilardi, Francesca Fioredda, Gabriella Casazza, Anna Pusiol, Michaela Calvillo, Ugo Ramenghi, Giovanni Palazzi, Baldassarre Martire, Marina Lanciotti, Fabio Tucci, Piero Farruggia, Angelica Barone, Tiziana Coliva, Daniela Renga, Carlo Dufour, Eleonora Gambineri, Giuseppe Menna, Sonia Bonanomi, Marta Pillon, Fioredda, F, Calvillo, M, Bonanomi, S, Coliva, T, Tucci, F, Farruggia, P, Pillon, M, Martire, B, Ghilardi, R, Ramenghi, U, Renga, D, Menna, G, Pusiol, A, Barone, A, Gambineri, E, Palazzi, G, Casazza, G, Lanciotti, M, and Dufour, C

Subjects
Pediatrics, medicine.medical_specialty, Consensus, Neutropenia, Bone marrow transplantation, MEDLINE, Consensu, Transplantation, Autologous, Drug Administration Schedule, Bone Marrow, Antineoplastic Combined Chemotherapy Protocols, Granulocyte Colony-Stimulating Factor, Medicine, Humans, Transplantation, Homologous, In patient, Disease management (health), Child, Transplantation, Homologou, Bone Marrow Transplantation, Antineoplastic Combined Chemotherapy Protocol, business.industry, Disease Management, Hematology, MED/38 - PEDIATRIA GENERALE E SPECIALISTICA, medicine.disease, Transplantation, Transplantation, Autologou, business, Human
Abstract

The management of congenital and acquired neutropenias presents some differences according to the type of the disease. Treatment with recombinant human granulocyte-colony stimulating factor (G-CSF) is not standardized and scanty data are available on the best schedule to apply. The frequency and the type of longitudinal controls in patients affected with neutropenias are not usually discussed in the literature. The Neutropenia Committee of the Marrow Failure Syndrome Group (MFSG) of the Associazione Italiana di Emato-Oncologia Pediatrica (AIEOP) elaborated this document following design and methodology formerly approved by the AIEOP board. The panel of experts reviewed the literature on the topic and participated in a conference producing a document that includes recommendations on neutropenia treatment and timing of follow-up. © 2011 Wiley Periodicals, Inc.

Published
2012

Catalog

Books, media, physical & digital resources
See catalog results